• 1. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 2. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Fatty acid positional distribution in colostrum and mature milk of women living in Inner Mongolia, North Jiangsu and Guangxi of China?
  Long Deng,Qian Zou,Biao Liu,Wenhui Ye,Chengfei Zhuo,Li Chen,Ze-Yuan Deng,Ya-Wei Fan,Jing Li Food Funct., 2018,9, 4234-4245

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Triazines 1,3,5-triazines Alkoxy-S-triazines

Introduction to N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide (CAS No. 2034358-84-2)

N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide is a sophisticated organic compound that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic synthesis. This compound, identified by its CAS number 2034358-84-2, represents a unique molecular architecture that combines a thiophene core with a triazine moiety, both of which are well-documented for their diverse biological activities. The presence of functional groups such as dimethylamino and methoxy further enhances its potential utility in drug discovery and medicinal chemistry.

The structural framework of N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide is characterized by its heterocyclic nature, which is a hallmark of many bioactive molecules. The thiophene ring, a five-membered aromatic system containing sulfur, is known for its role in various pharmacological applications. In contrast, the triazine group introduces additional complexity and reactivity, making it a valuable scaffold for medicinal chemists seeking to develop novel therapeutic agents.

In recent years, there has been a surge in research focused on the development of new heterocyclic compounds with potential therapeutic applications. The combination of thiophene and triazine in N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide has been explored for its ability to interact with biological targets in unique ways. This compound has shown promise in preliminary studies as a modulator of various cellular processes, including enzyme inhibition and receptor binding.

The methoxy group on the triazine ring not only contributes to the overall electronic properties of the molecule but also serves as a site for further functionalization. This flexibility allows researchers to modify the compound's properties and tailor its biological activity to specific needs. The dimethylamino substituent further enhances the molecule's potential by providing a basic nitrogen atom that can engage in hydrogen bonding or form salt bridges with biological targets.

One of the most compelling aspects of N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide is its potential as a lead compound for drug development. Its unique structural features have been investigated in various contexts, including their interaction with enzymes and receptors relevant to human health. For instance, studies have explored its potential as an inhibitor of certain kinases and other enzymes implicated in diseases such as cancer and inflammatory disorders.

The synthesis of this compound involves multiple steps that require careful optimization to ensure high yield and purity. The incorporation of the thiophene ring into the molecular structure necessitates precise control over reaction conditions to avoid unwanted side products. Advanced synthetic methodologies have been employed to achieve this goal, including palladium-catalyzed cross-coupling reactions and nucleophilic substitution processes.

In terms of biological activity, N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide has been evaluated in several in vitro assays. These studies have revealed promising results regarding its ability to modulate target proteins involved in disease pathways. For example, preliminary data suggest that this compound may exhibit inhibitory effects on certain enzymes that play a role in cell proliferation and survival.

The development of new pharmaceuticals often involves rigorous testing to assess both efficacy and safety. N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide is no exception and has undergone extensive characterization to understand its pharmacokinetic properties. These studies include assessments of solubility, stability, and metabolic degradation pathways. Such information is crucial for determining the feasibility of translating preclinical findings into clinical applications.

The integration of computational methods into drug discovery has significantly accelerated the process of identifying promising lead compounds like N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide. Molecular modeling techniques have been used to predict how this compound might interact with biological targets at the atomic level. These predictions provide valuable insights into potential binding modes and can guide further optimization efforts.

The future prospects for N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide are bright given its unique structural features and promising preclinical data. Further research is warranted to explore its full therapeutic potential and to develop it into a viable candidate for clinical trials. Collaborative efforts between synthetic chemists and biologists will be essential in realizing this goal.

In conclusion, N-{4-(dimethylamino)-6-methoxy-1,3,5-triazin-2-ylmethyl}thiophene-2-sulfonamide (CAS No. 2034358-84) represents an exciting advancement in pharmaceutical chemistry. Its novel structure and demonstrated biological activity make it a compelling candidate for further investigation in drug discovery efforts aimed at addressing unmet medical needs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)